United Health Products (UEEC) Common Equity (2010 - 2026)

United Health Products (UEEC) has 17 years of Common Equity data on file, last reported at -$4.2 million in Q1 2026.

• Common Equity for Q1 2026 came in at -$4.2 million, down 46.82% year-over-year; the trailing twelve-month figure through Mar 2026 was -$4.2 million (down 46.82% YoY), and the FY2025 annual result was -$3.9 million, down 58.62% from the prior year.
• Common Equity eased to -$4.2 million in Q1 2026 per UEEC's latest filing, from -$3.9 million in the prior quarter.
• Over five years, Common Equity peaked at -$1.7 million in Q4 2023 and troughed at -$4.2 million in Q1 2026.
• A 5-year average of -$2.4 million and a median of -$2.1 million in 2022 frame the typical range for Common Equity.
• The sharpest annual moves came in 2022 and 2023: Common Equity tumbled 4981.31% in 2022, then increased 21.42% in 2023.
• A 5-year view of Common Equity shows it stood at -$2.1 million in 2022, then advanced by 16.98% to -$1.7 million in 2023, then slumped by 42.56% to -$2.4 million in 2024, then tumbled by 58.62% to -$3.9 million in 2025, then slipped by 8.15% to -$4.2 million in 2026.
• Business Quant data shows UEEC's Common Equity at -$4.2 million in Q1 2026, -$3.9 million in Q4 2025, and -$3.3 million in Q3 2025.